期刊文献+

维思通与氯氮平治疗以阴性症状为主的精神分裂症的疗效对照研究 被引量:21

A controlled study of efficacy of risperidone and clozapine on treating schizophrenia whose predominant clinical features were negative symptoms
暂未订购
导出
摘要 目的探索维思通对以阴性症状为主的精神分裂症的疗效与副反应。方法对80例以阴性症状为主的精神分裂症住院患者,用维思通与氯氮平随机对照,采用SANS、BPRS和临床疗效总评进行评定。结果维思通的疗效优于氯氮平,而副反应发生率也较低。 bjective To probe into clinical therapy and side effect with risperidone in the treatment of schizophrenia whose predominant clinical features were negative symptoms Methods 80 cases of schizophrenia whose predominant clinical features were negative symptoms were randomly assigned to treatment with either risperidone or clozpine.Their therapeutic effects were evaluated with SANA,BPRS and the creteria of clinical curative effects.Results The therapeutic effects of risperidone were more potent than clozapine and the side effects were lighter.Conclusion Risperidone is preferred as an ideal agent in the treatment of schizophrenia whose predominant clinical features were negative symptoms.
出处 《四川精神卫生》 1998年第3期151-152,共2页 Sichuan Mental Health
关键词 精神分裂症 阴性症状 维思通 氯氮平 治疗 Schizophrenia Negative symptoms Risperidone Clozapine
  • 相关文献

同被引文献119

引证文献21

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部